Q32 Bio (QTTB) Capital Expenditures (QoQ) (2017 - 2025)
Q32 Bio (QTTB) Capital Expenditures (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 273.15% |
| Sep 30, 2025 | -449.44% |
| Jun 30, 2025 | -45.73% |
| Mar 31, 2025 | 29.13% |
| Dec 31, 2024 | -56.73% |
| Sep 30, 2024 | 687.00% |
| Jun 30, 2024 | -186.96% |
| Sep 30, 2023 | -96.30% |
| Jun 30, 2023 | 217.39% |
| Mar 31, 2023 | -355.56% |
| Dec 31, 2022 | 50.00% |
| Sep 30, 2022 | -99.50% |
| Jun 30, 2022 | 1,952.54% |
| Mar 31, 2022 | -97.50% |
| Dec 31, 2021 | 252.68% |
| Sep 30, 2021 | -227.43% |
| Jun 30, 2021 | 230.79% |
| Mar 31, 2021 | 164.73% |
| Dec 31, 2020 | -187.64% |
| Sep 30, 2020 | 132.30% |